Overview


According to FutureWise analysis the market for Implantable Cardiac Rhythm Management in 2023 is US$ 19.88 billion, and is expected to reach US$ 31.02 billion by 2031 at a CAGR of 5.72%.

Cardiac rhythm management devices perform functions like cardiac resynchronization in heart failure, bradycardia and defibrillation, monitoring of arrhythmias, and anti-tachycardia Pacing for tachyarrhythmias. Implants that manage abnormal heart rhythms are needed by many patients. Implantable cardiac rhythm management systems are the devices that achieve this goal. The implantable cardiac rhythm management device devices are able to allow patients to lead more active lives and lower their risk of dying from heart attacks and heart failure. In some cases, the patient should be cautious about electromagnetic interference. The growth in the global geriatric population is driving the growth of the implantable heart rhythm management market. Because older people are more vulnerable to developing cardiac conditions or disorders, this is why the market for implantable cardiac rhythm management has grown. A rise in heart strokes due to sedentary and fast-paced living is one of the key factors driving the market's growth. However, there are other factors that could hinder the market's growth over the forecast period. A device that may execute defibrillation depending on the type, cardioversion, and pacing of the heart is known as an implanted cardioverter-defibrillator (ICD) or automated implantable cardioverter-defibrillator (AICD). The ICD provides prophylactic treatment and first-line care for patients at increased risk for sudden cardiac deaths due to ventricular fibrillation, ventricular tachycardia, and ventricular tachycardia. Boston Scientific Corporation trademarked the term "AICD". Therefore, the preferred terminology is "ICD". A single-chamber ICD with its right side ventricular lead attached to the header. Please note that it starts at the tip of the lead and continues all the way to the first ring. This is used to sense and stimulate the right ventricle and the coil, as well as the two rings for atrial stimulation. Current battery technology can extend the life of current device batteries from six to ten years. With advances in technology, such as batteries with greater capacity or rechargeable batteries, it might be possible to extend this lifespan beyond ten to fifteen years. The average lifespan of the lead (the electric cable connecting the device and the heart) is much longer but it can experience various malfunctions, such as insulation failure or fracture. It will need to be replaced. The procedure of implanting an ICD device is the same as that of installing a pacemaker. ICDs can be composed of an ICD generator and wires. The first part of an ICD generator includes a computer chip or circuitry that has RAM (memory), programable software, and a cap. This is often placed under the skin at the left upper breast. The second part of the system includes an electrical wire. These are similar to pacemakers. They are connected through a vein and then passed to the right chambers.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Implantable Cardiac Rhythm Management Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Implantable Cardiac Rhythm Management Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Stryker
  • Schiller AG
  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Koninklijke Philips N.V.
  • Zoll Medical Corporation
  • BIOTRONIK
  • Nihon Kohden Corporation
  • Microport Scientific Corporation

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product Type

  • Pacemakers
  • Defibrillators
  • CRT
    • CRT-D
    • CRT-P
  • Implantable Loop recorder

By End-user

  • Hospital
  • Specialty Cardiac Centers
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Implantable Cardiac Rhythm Management Market By Product Type, By End-user and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Implantable Cardiac Rhythm Management Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Product Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Implantable Cardiac Rhythm Management Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Implantable Cardiac Rhythm Management Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Product Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Product Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Implantable Cardiac Rhythm Management Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Pacemakers
        2. Defibrillators
        3. CRT
         3.1. CRT-D
         3.2. CRT-P
        4. Implantable Loop recorder

  • 8.   Implantable Cardiac Rhythm Management Market, By End-user Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospital
        2. Specialty Cardiac Centers
        3. Others

  • 9.   North America Implantable Cardiac Rhythm Management Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Implantable Cardiac Rhythm Management Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Implantable Cardiac Rhythm Management Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Implantable Cardiac Rhythm Management Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Implantable Cardiac Rhythm Management Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Stryker
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Schiller AG
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Medtronic
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Abbott
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Boston Scientific Corporation
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Koninklijke Philips N.V.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Zoll Medical Corporation
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. BIOTRONIK
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Nihon Kohden Corporation
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Microport Scientific Corporation
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients